Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy

Bone Marrow Transplantation

Volumn 28, Issue 4, 2001, Pages 399-403

  Fassas, A ^a   Gojo, I ^a   Rapoport, A ^a   Cottler Fox, M ^a   Meisenberg, B ^b   Papadimitriou, J C ^b   Tricot, G ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CDEP chemotherapy; Fungal infection; Non infective pulmonary toxicity

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHYLPREDNISOLONE; THALIDOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COUGHING; DRUG INDUCED DISEASE; DRUG RESPONSE; DYSPNEA; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; LUNG INJURY; LUNG MYCOSIS; LUNG TOXICITY; MALE; MULTIPLE MYELOMA; PNEUMONIA; PRIORITY JOURNAL; STEROID THERAPY; SYMPTOM; THORAX RADIOGRAPHY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PNEUMONIA, PNEUMOCYSTIS; SYNDROME; TRANSPLANTATION CONDITIONING;

EID: 0034823765     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703147     Document Type: Article

References (11)

1. Pulmonary toxicity of antineoplastic therapy
2. Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer
3. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer
4. Post-transplantation (PT) intensive chemotherapy is feasible and results in prompt and complete hematologic recovery in patients with multiple myeloma and low grade lymphoma
5. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood
6. Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease
7. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation
8. Early-onset cyclophosphamide-induced interstitial pneumonitis
9. Lung toxicity associated with cyclophosphamide use. Two distinct patterns
10. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
11. Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer